FDA Adverse Event Injury Summary report: N

TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM

MDR report key: 2585834 · Received May 23, 2012

Report

Report Number
2134265-2012-02892
Event Type
Injury
Date Received
May 23, 2012
Date of Event
February 9, 2011
Report Date
April 26, 2012
Manufacturer
BOSTON SCIENTIFIC - MAPLE GROVE
Product Code
NIQ
PMA / PMN Number
P030025
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DEVICE IS A COMBINATION PRODUCT. DEVICE EVALUATED BY MFR: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).

Description of Event or Problem · 1

(B)(4) CLINICAL STUDY. SAME PATIENT AS MDR ID#: 2134265-2012-02396, 2134265-2012-02893, 213465-2012-03193. IT WAS REPORTED THAT FOLLOWING CORONARY ARTERY STENTING TREATMENT PROCEDURES, THE PATIENT HAD TOTAL OCCLUSION IN THE PREVIOUSLY TREATED VESSEL. THE PATIENT HAD A 2.50X20 MM TAXUS STENT PLACED IN THE SAPHENOUS VEIN GRAFT (SVG) TO RIGHT CORONARY ARTERY (RCA) IN (B)(6) 2005 AND A 3.50X20MM TAXUS STENT PLACED IN THE RCA IN (B)(6) 2008. IN (B)(6) 2011, THE PATIENT PRESENTED WITH MID-STERNAL CHEST PRESSURE WITH BILATERAL ARM DISCOMFORT AND ABNORMAL STRESS TEST. CORONARY ANGIOGRAPHY REVEALED TOTALLY OCCLUDED RCA AND SVG TO RCA. THESE LESIONS WERE CHRONICALLY OCCLUDED AND WERE NOT TREATED. NO MORE INFORMATION IS AVAILABLE AT THIS TIME AS THESE TWO PROCEDURES OCCURRED AT AN OUTSIDE HOSPITAL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC - MAPLE GROVE UNK432

Patients

Seq Age Sex Outcome Treatment
1 55 YR Other